Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126491041 | 12649104 | 1 | I | 20160729 | 20160812 | 20160812 | EXP | GB-JNJFOC-20160807455 | JANSSEN | 75.00 | YR | E | F | Y | 0.00000 | 20160812 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126491041 | 12649104 | 1 | PS | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | Oral | U | U | 20281 | 50 | MG | UNSPECIFIED | BID | |||||
| 126491041 | 12649104 | 2 | SS | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | Oral | Y | 0 | 20 | MG | UNSPECIFIED | BID | ||||||
| 126491041 | 12649104 | 3 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | Y | 0 | 500 | MG | UNSPECIFIED | BID | ||||||
| 126491041 | 12649104 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 25 | MG | UNSPECIFIED | QD | |||||||
| 126491041 | 12649104 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 75 | MG | UNSPECIFIED | QD | |||||||
| 126491041 | 12649104 | 6 | C | CYCLIZINE | CYCLIZINE | 1 | Oral | 0 | 50 | MG | UNSPECIFIED | ||||||||
| 126491041 | 12649104 | 7 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 100 | UG | UNSPECIFIED | QOD | |||||||
| 126491041 | 12649104 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 500 | MG | UNSPECIFIED | ||||||||
| 126491041 | 12649104 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 2.5 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126491041 | 12649104 | 1 | Product used for unknown indication |
| 126491041 | 12649104 | 2 | Product used for unknown indication |
| 126491041 | 12649104 | 3 | Product used for unknown indication |
| 126491041 | 12649104 | 4 | Product used for unknown indication |
| 126491041 | 12649104 | 5 | Product used for unknown indication |
| 126491041 | 12649104 | 6 | Product used for unknown indication |
| 126491041 | 12649104 | 7 | Product used for unknown indication |
| 126491041 | 12649104 | 8 | Product used for unknown indication |
| 126491041 | 12649104 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126491041 | 12649104 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126491041 | 12649104 | Constipation | |
| 126491041 | 12649104 | Dizziness | |
| 126491041 | 12649104 | Fatigue | |
| 126491041 | 12649104 | Haemoglobin decreased | |
| 126491041 | 12649104 | Presyncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126491041 | 12649104 | 2 | 20160503 | 0 | ||
| 126491041 | 12649104 | 3 | 20160503 | 0 |